Sa-nguanmoo, P., Tanajak, P., Kerdphoo, S., Jaiwongkam, T., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2018). SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.

Sa-nguanmoo, Piangkwan, Pongpan Tanajak, Sasiwan Kerdphoo, Thidarat Jaiwongkam, Wasana Pratchayasakul, Nipon Chattipakorn, و Siriporn C. Chattipakorn. SGLT2-inhibitor and DPP-4 Inhibitor Improve Brain Function Via Attenuating Mitochondrial Dysfunction, Insulin Resistance, Inflammation, and Apoptosis in HFD-induced Obese Rats. 2018.

Sa-nguanmoo, Piangkwan, et al. SGLT2-inhibitor and DPP-4 Inhibitor Improve Brain Function Via Attenuating Mitochondrial Dysfunction, Insulin Resistance, Inflammation, and Apoptosis in HFD-induced Obese Rats. 2018.